Commercial Information Circular

24-hour hotline : 23 922 922

e-mail address : enquiry@tid.gov.hk

Ref. :EIC 631/2/5/1

26 September 2017

Dear Sirs,

Commercial Information Circular No. 823/2017

The Mainland of China : Public Consultation on "Notice Concerning Adjustments to the Work related to the Acceptance of Registration of Drugs (Consultation Draft)"

The China Food and Drug Administration (CFDA) of the People's Republic of China is seeking comments from the public on the "Notice Concerning Adjustments to the Work related to the Acceptance of Registration of Drugs (Consultation Draft)".  Interested parties can submit their comments to the CFDA by email before 12 October 2017.  Please refer to the Appendix (pdf format) for the letter inviting public comments (available in Chinese only).

ENQUIRIES

2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct.  For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.

Yours faithfully,

(Calvin CHOY)
for Director-General of Trade and Industry

Note : While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.